Loss of GON4L Impairs Proliferation and Spheroid Growth in Luminal Breast Cancer Cells

Abstract

Objective: GON-4-like (GON4L) is a nuclear protein described as a putative transcriptional regulator with transcriptional repressive activity. Its oncogenic potential has been reported in bladder cancer through interactions with the transcription factor Yin Yang 1 (YY1), the corepressor SIN3 Transcription Regulator Family Member A (SIN3A), and Histone Deacetylase 1 (HDAC1). However, the functional role of GON4L in breast cancer remains largely unexplored. This study aimed to investigate the contribution of GON4L to breast cancer cell proliferation under both two-dimensional (2D) monolayer and threedimensional (3D) culture conditions. Materials and Methods: In this study, GON4L expression in breast cancer was analyzed using publicly available datasets (UALCAN, TNMplot) and quantitative reverse transcription polymerase chain reaction (RT-qPCR) in cell lines. GON4L was knocked-down in the MCF7 breast cancer cell line using the CRISPR-Cas9 gene editing system. The impact of GON4L loss on cellular proliferation was assessed through green fluorescent protein (GFP)-based competition and colony formation assays under 2D conditions, as well as spheroid formation assays in 3D culture systems. Statistical analyses were performed using Student's t-test. Results: GON4L expression was significantly elevated in breast cancer patient samples, including metastatic tissues. Compared with the non-tumorigenic breast epithelial cell line MCF-12A, GON4L expression was increased in MCF7 cells cultured under both 2D and 3D conditions. Genetic loss of GON4L resulted in a marked reduction in short- and long-term proliferative capacity in 2D culture systems and significantly impaired spheroid formation and growth in 3D cultures. These findings indicate that GON4L is required for sustained proliferation and maintenance of tumor-like architecture in breast cancer cells. Conclusion: Our results identify GON4L as a functionally important transcriptional regulator supporting proliferative capacity and structural organization in breast cancer cells, particularly under tumor-mimicking 3D conditions. Further investigation of GON4L-dependent regulatory mechanisms may provide insight into its potential relevance in breast cancer progression.

Keywords

• breast cancer
• GON4L
• CRISPR-Cas9
• three dimensional cell culture
• spheroid model

References

1. Siegel RL, Kratzer TB, Giaquinto AN, Sung H, Jemal A. Cancer statistics, 2025. CA Cancer J Clin 2025 75(1): 10-45. google scholar
2. Harbeck N, Penault-Llorca F, Cortes J, Gnant M, Houssami N, Poortmans P, et al. Breast cancer. Nat Rev Dis Primers 2019 5(1): 66. google scholar
3. Harbeck N, Gnant M. Breast cancer. Lancet 2017 389(10074): 1134-50. google scholar
4. Colgan DF, Goodfellow RX, Colgan JD. The transcriptional regulator GON4L is required for viability and hematopoiesis in mice. Exp Hematol 2021 98: 25-35. google scholar
5. Williams MLK, Sawada A, Budine T, Yin C, Gontarz P, Solnica-Krezel L. Gon4l regulates notochord boundary formation and cell polarity underlying axis extension by repressing adhesion genes. Nat Commun 2018 9(1): 1319. google scholar
6. Tsai SM, Chu KC, Jiang YJ. Newly identified Gon4l/Udu-interacting proteins implicate novel functions. Sci Rep 2020 10(1): 14213. google scholar
7. Lu P, Hankel IL, Hostager BS, Swartzendruber JA, Friedman AD, Brenton JL, et al. The developmental regulator protein Gon4l associates with protein YY1, co-repressor Sin3a, and histone deacetylase 1 and mediates transcriptional repression. J Biol Chem 2011 286(20): 18311-19. google scholar
8. Agarwal N, Dancik GM, Goodspeed A, Costello JC, Owens C, Duex JE, et al. GON4L drives cancer growth through a YY1-androgen receptor-CD24 axis. Cancer Res 2016 76(17): 5175-85. google scholar

9. Bloise N, Giannaccari M, Guagliano G, Peluso E, Restivo E, Strada S, et al. Growing role of 3D in vitro cell cultures in the study of cellular and molecular mechanisms: short focus on breast cancer, endometriosis, liver and infectious diseases. Cells 2024 13(12): 1054. google scholar
10. Habanjar O, Diab-Assaf M, Caldefie-Chezet F, Delort L. 3D cell culture systems: tumor application, advantages, and disadvantages. Int J Mol Sci 2021 22(22): 12200. google scholar
11. Barbosa MAG, Xavier CPR, Pereira RF, Petrikaitė V, Vasconcelos MH. 3D cell culture models as recapitulators of the tumor microenvironment for the screening of anti-cancer drugs. Cancers (Basel) 2022 14(1): 190. google scholar
12. Sanjana NE, Shalem O, Zhang F. Improved vectors and genome-wide libraries for CRISPR screening. Nat Methods 2014 11(8): 783-4. google scholar
13. Shalem O, Sanjana NE, Hartenian E, Shi X, Scott DA, Mikkelson T, et al. Genome-scale CRISPR-Cas9 knockout screening in human cells. Science 2014 343(6166): 84-7. google scholar
14. Chandrashekar DS, Karthikeyan SK, Korla PK, Patel H, Shovon AR, Athar M, et al. UALCAN: an update to the integrated cancer data analysis platform. Neoplasia 2022 25: 18-27. google scholar
15. Bartha Á, Győrffy B. TNMplot.com: a web tool for the comparison of gene expression in normal, tumor and metastatic tissues. Int J Mol Sci 2021 22(5): 2622. google scholar
16. Özkan H, Öztürk DG, Korkmaz G. Transcriptional factor repertoire of breast cancer in 3D cell culture models. Cancers (Basel) 2022 14(4): 1023. google scholar
17. Pampaloni F, Reynaud EG, Stelzer EHK. The third dimension bridges the gap between cell culture and live tissue. Nat Rev Mol Cell Biol 2007 8(10): 839-45. google scholar